Analog Century Management LP Invests $51.41 Million in Astera Labs, Inc. $ALAB

by · The Cerbat Gem

Analog Century Management LP purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 309,013 shares of the company’s stock, valued at approximately $51,407,000. Astera Labs accounts for approximately 2.5% of Analog Century Management LP’s holdings, making the stock its 21st largest position.

Other large investors have also made changes to their positions in the company. Eurizon Capital SGR S.p.A. acquired a new position in shares of Astera Labs in the 4th quarter valued at $18,708,000. Nordea Investment Management AB acquired a new position in shares of Astera Labs in the 4th quarter valued at $2,028,000. Geneva Partners LLC acquired a new position in shares of Astera Labs in the 3rd quarter valued at $1,876,000. Numerai GP LLC increased its position in shares of Astera Labs by 153.1% in the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after acquiring an additional 7,992 shares during the period. Finally, Swedbank AB increased its position in shares of Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after acquiring an additional 33,940 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on ALAB shares. Morgan Stanley upped their target price on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Rothschild & Co Redburn started coverage on Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price on the stock. Citigroup downgraded Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. Jefferies Financial Group reissued a “buy” rating and issued a $270.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Finally, Roth Mkm reissued a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $233.75.

Check Out Our Latest Analysis on Astera Labs

Insider Buying and Selling

In related news, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares of the company’s stock, valued at approximately $702,214,489.08. This represents a 7.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 2,321,256 shares of company stock valued at $480,893,146. 10.40% of the stock is owned by company insiders.

Astera Labs Trading Down 0.1%

NASDAQ ALAB opened at $367.15 on Friday. The stock has a market capitalization of $62.93 billion, a price-to-earnings ratio of 248.07, a PEG ratio of 4.86 and a beta of 3.95. Astera Labs, Inc. has a twelve month low of $84.78 and a twelve month high of $390.99. The stock has a 50-day moving average of $237.17 and a 200 day moving average of $178.94.

Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.Astera Labs’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Astera Labs Company Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Further Reading

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).